Revalidation may perform voluntarily

Published: 2009-11-23 06:59:00

Updated: 2009-11-23 06:59:00

A drug maker will be allowed to conduct revalidation voluntarily over sterile or non-sterile medicinal products, once the overall manufacturing method or facility/equipment was already validated, according to the Korea Food and Drug Administration.

The current regulation requires that prospect...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK